𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion

✍ Scribed by Shereen Keleg; Hany Kayed; Xiaohua Jiang; Roland Penzel; Thomas Giese; Markus W. Büchler; Helmut Friess; Jörg Kleeff

Publisher
John Wiley and Sons
Year
2007
Tongue
French
Weight
920 KB
Volume
121
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Adrenomedullin (ADM) is synthesized by different types of cells and acts by binding calcitonin receptor‐like receptor (CRLR) and members of the receptor activity‐modifying protein (RAMP) family. In this study, the expression and functional role of ADM and its signaling components were investigated in pancreatic adenocarcinoma (PDAC). By QRT‐PCR, median mRNA levels of ADM and CRLR were 1.5‐ and 2.4‐fold higher, respectively, in PDAC tissues compared to normal pancreatic tissues. By immunohistochemistry, ADM, CRLR, RAMP1 and RAMP2, but not RAMP3, were expressed in pancreatic cancer cells. ADM serum levels were significantly increased in PDAC patients compared to healthy controls and chronic pancreatitis (CP) patients, with an area under the ROC curve of 0.83 and 0.98, respectively. At a cut‐off level of 30.6 ng/ml, the specificity of ADM to differentiate PDAC from controls and CP patients was 85.5 and 83.6%, with a sensitivity of 80 and 100%. All 5 evaluated pancreatic cancer cells lines expressed ADM, CRLR, RAMP1 and RAMP2, whereas RAMP3 was expressed in only 1/5 pancreatic cancer cell lines. ADM was strongly induced by hypoxia and significantly increased invasiveness in 3/5 human pancreatic cancer cells. Blocking of CRLR decreased invasiveness in 4/5 human pancreatic cancer cells. In addition, rADM slightly up‐regulated vascular endothelial growth factor secretion in 3/5 cell lines. In conclusion, ADM is induced by hypoxia and over‐expressed in PDAC and might therefore serve as a potential tumor marker. Furthermore, ADM increases invasiveness of some pancreatic cancer cells and might influence angiogenesis, suggesting that blocking this pathway might have a therapeutic potential. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Kallikrein 7 enhances pancreatic cancer
Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin
✍ Sarah K. Johnson; Vishnu C. Ramani; Leah Hennings; Randy S. Haun 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB

## Abstract ## BACKGROUND. Pancreatic cancer (PaC) is characterized by local invasion and early metastasis. Serine proteases have been associated with invasion and metastasis of many cancers due to their ability to degrade extracellular matrix (ECM) proteins and to activate other proteases; thus,

Nerve growth factor and enhancement of p
Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells
✍ Zhaowen Zhu; Jörg Kleeff; Hany Kayed; Li Wang; Murray Korc; Markus W. Büchler; H 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Abstract Nerve growth factor (NGF) exerts both stimulatory and inhibitory effects on neuronal and certain non‐neuronal tumors. In pancreatic cancer NGF is overexpressed, and this overexpression is associated with increased perineural invasion. NGF has the potential to stimulate the growth of som

TGF-β–induced invasiveness of pancreatic
TGF-β–induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system
✍ Volker Ellenrieder; Sandra F. Hendler; Claudia Ruhland; Wolfgang Boeck; Guido Ad 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 216 KB

TGF-beta strongly promotes local tumor progression in advanced epithelial tumors, though the underlying mechanisms are poorly understood. In the present study, we demonstrate the potential of TGF-beta to increase the invasiveness of the pancreatic cancer cell lines PANC-1 and IMIM-PC1. TGF-beta-indu

Geminin is overexpressed in human pancre
Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines
✍ Mohammad R. Salabat; Laleh G. Melstrom; Matthew J. Strouch; Xian-Zhong Ding; Ben 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

## Abstract Pancreatic adeniocarcinoma is among the deadliest of human cancers. Apigenin, an antitumor flavonoid, inhibits pancreatic cancer cell proliferation in vitro. Geminin is a recently identified novel protein that plays a critical role in preventing abnormal DNA replication by binding to an